BA
TARO

BlackRock Advisors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

BlackRock Advisors’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$705K Sell
6,699
-44
-0.7% -$4.61K ﹤0.01% 2025
2016
Q3 		$745K Buy
6,743
+3,381
+101% +$448K ﹤0.01% 1966
2016
Q2 		$490K Buy
3,362
+1,657
+97% +$235K ﹤0.01% 2128
2016
Q1 		$244K Buy
1,705
+75
+5% +$10.7K ﹤0.01% 2460
2015
Q4 		$252K Buy
+1,630
New +$238K ﹤0.01% 2443

Other funds holding TARO

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock Advisors's TARO Position: Q4 2016 in Review

BlackRock Advisors reduced its Taro Pharmaceutical Industries Ltd. (TARO) stake by 0.65% in Q4 2016, selling an estimated $4.61K and leaving 6,699 shares worth $705K. The position accounts for ﹤0.01% of the portfolio, ranked #2025.

BlackRock Advisors first reported a position in TARO in Q4 2015 and has held it in 5 quarters since. The position peaked at $745K in Q3 2016. 151 funds tracked by Wall St. Rank hold TARO as of Q4 2016.

  • BlackRock Advisors held 6,699 shares of Taro Pharmaceutical Industries Ltd. worth $705K as of Q4 2016.
  • BlackRock Advisors sold 44 Taro Pharmaceutical Industries Ltd. shares in Q4 2016, an estimated $4.61K.
  • Taro Pharmaceutical Industries Ltd. made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2025 holding.
  • BlackRock Advisors first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2015 and has held it in 5 quarters since.
  • BlackRock Advisors's Taro Pharmaceutical Industries Ltd. position peaked at $745K in Q3 2016.
  • 151 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.